NovaBay Pharmaceuticals Announces 1-for-5 Reverse Stock Split

By Chris Stiles • Thursday, February 12 12:56 • Permanent Link

Novabay Pharmaceuticals, Inc. (NYSE American: NBY) has announced a 1-for-5 reverse stock split, effective as of 4:15 p.m. New York City time on Friday, February 20, 2026. As a result, the number of shares of common stock issued and outstanding will be reduced from approximately 130,623,400 shares to approximately 26,124,680 shares.

This reverse stock split will combine every 5 shares of outstanding company common stock into 1 share of common stock. The company will issue an additional whole share to all holders who would otherwise receive a fractional share of common stock. All outstanding options, restricted stock awards, warrants, preferred stock, convertible debentures, and other company securities entitling their holders to purchase, exercise, convert, or otherwise receive shares of common stock will be adjusted as a result of the reverse stock split.

The company anticipates that the reverse stock split will increase the per-share price of its common stock, which it believes will enable it to comply with the NYSE American's continued-listing requirement relating to the price of its common stock. The company's trading symbol of “NBY” will not change as a result of the reverse stock split, but a new CUSIP number has been assigned: 66987P 508.

Equiniti Trust Company, LLC is acting as the exchange agent and transfer agent for the reverse stock split and will provide instructions to stockholders with physical certificates regarding the process for exchanging their pre-split stock certificates for post-split shares.

Novabay Pharmaceuticals, historically focused on the development and sale of scientifically created and clinically proven eyecare, wound care, and skin care products, completed a comprehensive realignment of its business in early 2026. It adopted a capital allocation strategy focused on acquiring digital assets that provide exposure to economic participation within open digital financial networks. Today the company's shares have moved 16.39% to a price of $14.77. Check out the company's full 8-K submission here.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.